Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)-Reference-Cited by-同舟云学术

Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)

Published:2014-06-09 Issue:3 Volume:29 Page:452-456
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Hägg D.¹²,Sundström A.³,Eriksson M.⁴,Schmitt-Egenolf M.¹

Affiliation:

1. Dermatology, Medicine; Department of Public Health and Clinical Medicine; Umeå University Umeå; Umeå Sweden

2. Industrial Doctoral School; Umeå University; Umeå Sweden

3. Karolinska Institutet; Centre for Pharmacoepidemiology; Solna Sweden

4. Department of Statistics; Umeå School of Business and Economics; Umeå University; Umeå Sweden

Funder

Swedish Board of Health and Welfare

Swedish Association of Local Authorities and Regions

Västerbotten County Council

Industrial Doctoral School

Umeå University

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12576/fullpdf

Reference21 articles.

1. Investigators IDIMPRoVE. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis;Sampogna;J Invest Dermatol,2004

2. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany;Augustin;Acta Derm Venereol,2010

3. Psoriasis causes as much disability as other major medical diseases;Rapp;J Am Acad Dermatol,1999

4. The impact of psoriasis on quality of life;Arruda;Br J Dermatol,2001

5. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre;Warren;Br J Dermatol,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Socioeconomic Factors on Access to Biologics in Psoriasis;Journal of Clinical Medicine;2023-11-22

2. Treatment outcomes of secukinumab in adult patients with moderate‐to‐severe plaque psoriasis in China: A real‐world multicenter retrospective study;Clinical and Translational Science;2023-08-29

3. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study;Annals of Medicine;2023-07-07

4. Economic Evaluation of Selected Interleukin Inhibitors Versus Methotrexate for Moderate-to-Severe Plaque Psoriasis From the Philippine Payer Perspective;Value in Health Regional Issues;2023-03

5. Psoriatic Foot Involvement is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China;Clinical, Cosmetic and Investigational Dermatology;2023-02